T44 |
 |
Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system  |
| |
char7Note |
The appropriate 7th character is to be added to each code from category T44
|
char7Def |
A: initial encounter D: subsequent encounter S: sequela
|
|
| |
T44.0 |
|
Poisoning by, adverse effect of and underdosing of anticholinesterase agents |
| |
T44.0X |
|
Poisoning by, adverse effect of and underdosing of anticholinesterase agents |
| |
T44.0X1 |
 |
Poisoning by anticholinesterase agents, accidental (unintentional) |
| |
Poisoning by anticholinesterase agents NOS |
|
| | |
T44.0X2 |
|
Poisoning by anticholinesterase agents, intentional self-harm |
| | |
T44.0X3 |
|
Poisoning by anticholinesterase agents, assault |
| | |
T44.0X4 |
|
Poisoning by anticholinesterase agents, undetermined |
| | |
T44.0X5 |
|
Adverse effect of anticholinesterase agents |
| | |
T44.0X6 |
|
Underdosing of anticholinesterase agents |
| | |
| |
T44.1 |
|
Poisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics] |
| |
T44.1X |
|
Poisoning by, adverse effect of and underdosing of other parasympathomimetics [cholinergics] |
| |
T44.1X1 |
 |
Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional) |
| |
Poisoning by other parasympathomimetics [cholinergics] NOS |
|
| | |
T44.1X2 |
|
Poisoning by other parasympathomimetics [cholinergics], intentional self-harm |
| | |
T44.1X3 |
|
Poisoning by other parasympathomimetics [cholinergics], assault |
| | |
T44.1X4 |
|
Poisoning by other parasympathomimetics [cholinergics], undetermined |
| | |
T44.1X5 |
|
Adverse effect of other parasympathomimetics [cholinergics] |
| | |
T44.1X6 |
|
Underdosing of other parasympathomimetics [cholinergics] |
| | |
| |
T44.2 |
|
Poisoning by, adverse effect of and underdosing of ganglionic blocking drugs |
| |
T44.2X |
|
Poisoning by, adverse effect of and underdosing of ganglionic blocking drugs |
| |
T44.2X1 |
 |
Poisoning by ganglionic blocking drugs, accidental (unintentional) |
| |
Poisoning by ganglionic blocking drugs NOS |
|
| | |
T44.2X2 |
|
Poisoning by ganglionic blocking drugs, intentional self-harm |
| | |
T44.2X3 |
|
Poisoning by ganglionic blocking drugs, assault |
| | |
T44.2X4 |
|
Poisoning by ganglionic blocking drugs, undetermined |
| | |
T44.2X5 |
|
Adverse effect of ganglionic blocking drugs |
| | |
T44.2X6 |
|
Underdosing of ganglionic blocking drugs |
| | |
| |
T44.3 |
 |
Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics |
| |
Poisoning by, adverse effect of and underdosing of papaverine |
|
| |
T44.3X |
|
Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics |
| |
T44.3X1 |
 |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional) |
| |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics NOS |
|
| | |
T44.3X2 |
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm |
| | |
T44.3X3 |
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault |
| | |
T44.3X4 |
|
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined |
| | |
T44.3X5 |
|
Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics |
| | |
T44.3X6 |
|
Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics |
| | |
| |
T44.4 |
 |
Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists |
| |
Poisoning by, adverse effect of and underdosing of metaraminol |
|
| |
T44.4X |
|
Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists |
| |
T44.4X1 |
 |
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional) |
| |
Poisoning by predominantly alpha-adrenoreceptor agonists NOS |
|
| | |
T44.4X2 |
|
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm |
| | |
T44.4X3 |
|
Poisoning by predominantly alpha-adrenoreceptor agonists, assault |
| | |
T44.4X4 |
|
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined |
| | |
T44.4X5 |
|
Adverse effect of predominantly alpha-adrenoreceptor agonists |
| | |
T44.4X6 |
|
Underdosing of predominantly alpha-adrenoreceptor agonists |
| | |
| |
T44.5 |
 |
Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists |
| |
Excludes1 |
poisoning by, adverse effect of and underdosing of beta-adrenoreceptor agonists used in asthma therapy (T48.6-)
|
|
| |
T44.5X |
|
Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists |
| |
T44.5X1 |
 |
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional) |
| |
Poisoning by predominantly beta-adrenoreceptor agonists NOS |
|
| | |
T44.5X2 |
|
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm |
| | |
T44.5X3 |
|
Poisoning by predominantly beta-adrenoreceptor agonists, assault |
| | |
T44.5X4 |
|
Poisoning by predominantly beta-adrenoreceptor agonists, undetermined |
| | |
T44.5X5 |
|
Adverse effect of predominantly beta-adrenoreceptor agonists |
| | |
T44.5X6 |
|
Underdosing of predominantly beta-adrenoreceptor agonists |
| | |
| |
T44.6 |
 |
Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists |
| |
Excludes1 |
poisoning by, adverse effect of and underdosing of ergot alkaloids (T48.0)
|
|
| |
T44.6X |
|
Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists |
| |
T44.6X1 |
 |
Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional) |
| |
Poisoning by alpha-adrenoreceptor antagonists NOS |
|
| | |
T44.6X2 |
|
Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm |
| | |
T44.6X3 |
|
Poisoning by alpha-adrenoreceptor antagonists, assault |
| | |
T44.6X4 |
|
Poisoning by alpha-adrenoreceptor antagonists, undetermined |
| | |
T44.6X5 |
|
Adverse effect of alpha-adrenoreceptor antagonists |
| | |
T44.6X6 |
|
Underdosing of alpha-adrenoreceptor antagonists |
| | |
| |
T44.7 |
|
Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists |
| |
T44.7X |
|
Poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists |
| |
T44.7X1 |
 |
Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional) |
| |
Poisoning by beta-adrenoreceptor antagonists NOS |
|
| | |
T44.7X2 |
|
Poisoning by beta-adrenoreceptor antagonists, intentional self-harm |
| | |
T44.7X3 |
|
Poisoning by beta-adrenoreceptor antagonists, assault |
| | |
T44.7X4 |
|
Poisoning by beta-adrenoreceptor antagonists, undetermined |
| | |
T44.7X5 |
|
Adverse effect of beta-adrenoreceptor antagonists |
| | |
T44.7X6 |
|
Underdosing of beta-adrenoreceptor antagonists |
| | |
| |
T44.8 |
 |
Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic-neuron- blocking agents |
| |
Excludes2 |
poisoning by, adverse effect of and underdosing of clonidine (T46.5) poisoning by, adverse effect of and underdosing of guanethidine (T46.5)
|
|
| |
T44.8X |
|
Poisoning by, adverse effect of and underdosing of centrally-acting and adrenergic- neuron-blocking agents |
| |
T44.8X1 |
 |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional) |
| |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents NOS |
|
| | |
T44.8X2 |
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm |
| | |
T44.8X3 |
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault |
| | |
T44.8X4 |
|
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined |
| | |
T44.8X5 |
|
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents |
| | |
T44.8X6 |
|
Underdosing of centrally-acting and adrenergic-neuron-blocking agents |
| | |
| |
T44.9 |
 |
Poisoning by, adverse effect of and underdosing of other and unspecified drugs primarily affecting the autonomic nervous system |
| |
Poisoning by, adverse effect of and underdosing of drug stimulating both alpha and beta-adrenoreceptors |
|
| |
T44.90 |
|
Poisoning by, adverse effect of and underdosing of unspecified drugs primarily affecting the autonomic nervous system |
| |
T44.901 |
 |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional) |
| |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system NOS |
|
| | |
T44.902 |
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm |
| | |
T44.903 |
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault |
| | |
T44.904 |
|
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined |
| | |
T44.905 |
|
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system |
| | |
T44.906 |
|
Underdosing of unspecified drugs primarily affecting the autonomic nervous system |
| | | |
T44.99 |
|
Poisoning by, adverse effect of and underdosing of other drugs primarily affecting the autonomic nervous system |
| |
T44.991 |
 |
Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional) |
| |
Poisoning by other drugs primarily affecting the autonomic nervous system NOS |
|
| | |
T44.992 |
|
Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm |
| | |
T44.993 |
|
Poisoning by other drug primarily affecting the autonomic nervous system, assault |
| | |
T44.994 |
|
Poisoning by other drug primarily affecting the autonomic nervous system, undetermined |
| | |
T44.995 |
|
Adverse effect of other drug primarily affecting the autonomic nervous system |
| | |
T44.996 |
|
Underdosing of other drug primarily affecting the autonomic nervous system |
| | |